Furthermore, we found a decreased Adpn/Lep ratio in patients with the metabolic syndrome [28] and a gradual reduction with increasing number of risk factors for metabolic syndrome has been also reported [29,30]. This evidence concerns the gene ADIPOQ and metabolic syndrome.